Aspen Aerogels (ASPN) is expected to deliver robust revenue growth during 2019, and the market estimates it will be growing wonderfully in the following years. Investing in the company presents an optimal risk-reward proposition with a dream come actual downside and extraordinary upside potential, and as for its price, it is overvalued.
Aspen Aerogels is a micro-cap company with a market cap of about $170 Million with decent financials.
The technology is impressive, the revenue outlook is robust, and management is excellent. The only issue is the gross margin; the total valuation is